drugset / Trial / NCT02944201
Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate
NaSingle-groupOpen-labelTreatment
Summary
This will be a single arm, window of opportunity study in men with treatment-naïve prostate cancer who will proceed to prostatectomy. Men will be treated with carvedilol prior to undergoing prostatectomy.
Timeline
- Start
- 2017-04-01
- Primary completion
- 2020-12-31
- Completion
- 2021-12-31
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carvedilol | Other / unclassified | 6.25 mg | Oral |